Evidence map›Paper›PMID 31618757›Full record

ArticleNature2019

HP1 reshapes nucleosome core to promote phase separation of heterochromatin.

S Sanulli, M J Trnka, V Dharmarajan, R W Tibble, B D Pascal, A L Burlingame, P R Griffin, J D Gross, G J Narlikar

Abstract read
In one paragraph

Article in Nature, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 306 papers.

0numbers the graph read from it
0cells of the map it votes in
306citing papers in PubMed
24.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

306 citing papers in PubMed, 511 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Investigating Phase Separation in Genome Folding via Multiscale Computational Modeling.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Mapping Allosteric Communication in the Nucleosome with Conditional Activity.Journal of chemical information and modeling · 2026
    Article
  18. Article
  19. Article
  20. Article

246 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

S SanulliDepartment of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.
M J TrnkaDepartment of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.
V DharmarajanDepartment of Molecular Medicine, The Scripps Research Institute, Jupiter, FL, USA.
R W TibbleDepartment of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.
B D PascalDepartment of Molecular Medicine, The Scripps Research Institute, Jupiter, FL, USA.
A L BurlingameDepartment of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.
P R GriffinDepartment of Molecular Medicine, The Scripps Research Institute, Jupiter, FL, USA.
J D GrossDepartment of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA. jdgross@cgl.ucsf.edu.
G J NarlikarDepartment of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA. geeta.narlikar@ucsf.edu.
University of California, San Francisco · USScripps Research Institute · US

Funding

Engaging University of California Stakeholders for Biorespository ResearchUL1TR000004 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$78.0M
RESEARCH TRAINING IN CHEMISTRY AND CHEMICAL BIOLOGYT32GM064337 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CRAIK, CHARLES SCOTT · 2002 to 2021
$7.8M
Measuring the lifetime and mechanical stability of phase-separated heterochromatin domainsR35GM127020 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GEETA J NARLIKAR · 2018 to 2026
$7.3M
Bio-Organic Biomedical Mass Spectromy ResourceP41GM103481 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BURLINGAME, ALMA L · 2012 to 2015
$6.4M
Structure and Function of the Decapping Enzyme ComplexR01GM078360 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GROSS, JOHN D · 2009 to 2018
$2.5M
Conformational Control of Heterochromatin Formation by the HP-1 Protein fromFission YeastR01GM121962 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GROSS, JOHN D · 2017 to 2020
$1.9M
Mechanistic dissection of HP1 mediated heterochromatinR01GM108455 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NARLIKAR, GEETA J · 2014 to 2017
$1.7M
Purchase of Q-Exactive Mass SpectrometerS10OD016229 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BURLINGAME, ALMA L · 2013 to 2013
$507k
NCATS NIH HHS UL1 TR000004NIGMS NIH HHS P41 GM103481NIGMS NIH HHS R01 GM078360NIGMS NIH HHS R01 GM108455NIGMS NIH HHS R01 GM121962NIGMS NIH HHS R35 GM127020NIGMS NIH HHS T32 GM064337NIH HHS S10 OD016229
6 · The paper itself

Abstract

Heterochromatin affects genome function at many levels. It enables heritable gene repression, maintains chromosome integrity and provides mechanical rigidity to the nucleus

Indexed as

Chromatin Assembly and DisassemblySchizosaccharomycesChromosomal Proteins, Non-HistoneHeterochromatinHistonesModels, MolecularNucleosomesSchizosaccharomyces pombe ProteinsSolventsChromosomal Proteins, Non-HistoneHeterochromatinHistonesNucleosomesSchizosaccharomyces pombe ProteinsSolventsSwi6 protein, S pombe

Identifiers

PMID31618757
PMCPMC7039410
OpenAlexW2980597982

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.